DUBLIN--(BUSINESS WIRE)--Aug 17, 2018--The "Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Size, Share & Trends Analysis Report By Procedure (Transapical, Transfemoral, Transaortic), By Country, Vendor Landscape, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global transcatheter aortic valve replacement (TAVR) devices market size is anticipated to reach USD 12.2 billion by 2025, progressing at a CAGR of 22.6% during the forecast period.

Increasing incidence of cardiovascular diseases and severe aortic stenosis disorder are among key factors augmenting the TAVR device market. Moreover, rising number of various clinical trials such as Edwards SAPIEN 3 and Medtronic Transcatheter Aortic Valve 2.0 Replacement System are likely to contribute to the growth of the market during the forecast period.

Improvements in surgical techniques and quality of implantable valves are leading to an increase in the adoption of aortic valve replacement procedures. Moreover, surging demand for minimally invasive surgeries as compared to traditional open heart procedures, availability of reimbursement for surgical procedures, and growing inclination of physicians towards TAVR procedures are projected to boost the growth of the market.

Launch of new devices with advanced technology for fast and effective treatment is poised to propel the market. For instance, in April 2016, St. Jude Medical launched a new device - Trifecta Valve with glide technology to be used in both conventional as well as minimally invasive procedures.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Market Definitions

Chapter 3 Research Methodology

Chapter 4 Market Variables, Trends & Scope

Chapter 5 Regulatory Framework

Chapter 6 Transcatheter Aortic Valve Replacement (TAVR) Market: By Procedure Estimates & Trend Analysis

Chapter 7 Transcatheter Aortic Valve Replacement (TAVR) Market: By Device Estimates & Trend Analysis

Chapter 8 Transcatheter Aortic Valve Replacement (TAVR) Market: Regional Estimates & Trend Analysis

Chapter 9 Competitive Landscape

Medtronic plc Boston Scientific Corporation Meril Life Sciences Pvt. Ltd., Inc. Edwards Lifesciences Corporation St. Jude Medical, Inc. JenaValve Technology, Inc. Bracco SpA Transcatheter Technologies GmbH Abbott

For more information about this report visit https://www.researchandmarkets.com/research/bb37gt/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180817005187/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Devices



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/17/2018 08:58 AM/DISC: 08/17/2018 08:58 AM